Member Directory

D Young & Co is a leading intellectual property firm. We are proactive, insightful and international and our Life Science team is one of the leading IP practices in Europe. Clients choose D Young & Co for IP services confident in the knowledge, experience and dedication that has characterised our work throughout our firm’s history.

DefiniGEN is a game-changing company headquartered in Cambridge, UK, with a mission to navigate drug development programs through uncertain terrain, minimizing risk while reducing costs and paving the way for a more efficient and effective future in the field of drug discovery. Our technology is revolutionizing liver models for efficacy and toxicology screening, utilizing a platform that enables the large-scale generation of hepatocyte-like cells ( Opti-Heps) with functional relevance comparable to human primary cells.
Our Opti-Heps effectively simulate crucial aspects of disease pathophysiology across various liver conditions, providing a more accurate understanding for drug development. By integrating CRISPR/Cas9 technology, DefiniGEN replicates disease phenotypes catering to unmet needs for in vitro efficacy testing and enabling the study of previously inaccessible rare monogenic liver diseases. Our Opti-Heps successfully replicate all aspects of hepatocyte pathophysiology, allowing them to replace primary liver cells in many aspects of toxicity testing. This breakthrough provides scientists with a reliable and consistent supply of highly functional hepatocytes for the first time.

Deloitte is the UK's fastest growing professional services firm in locations across the UK, with over 10,000 staff worldwide. Deloitte offers integrated services including audit, tax, consulting and corporate finance. Our approach combines insight and innovation from multiple disciplines with business and industry knowledge to help our clients excel anywhere in the world. We deliver outstanding impact on the reputation and success of our clients, in the UK and globally. Our industry specialists from across Deloitte provide an extensive depth of knowledge on the range of current issues experienced by the pharmaceuticals, biotechnology, medical devices and private healthcare industries.

DIOSVax is a biotech startup working to revolutionise the way humanity protects itself from infectious disease and emerging pathogens.

We've developed a novel technology to significantly increase the protective ability of vaccines, and develop them on a dramatically accelerated timeline. The system is currently in use to develop vaccines against Ebola, flu, and other deadly pathogens.

Discovery Park in Sandwich, Kent is a global leader for science and enterprise with world class laboratories and exceptional office space. The site has a track record for drug discovery stretching back to the 1950’s and continues to lead the way in R&D from the search for new antibiotics to pioneering research across the life sciences; from developing new therapeutics and diagnostics to unlocking the full potential of immunotherapy and immuno-oncology.

As well as industry-leading laboratories for R&D and bespoke office space, we can help businesses searching for the right location to manufacture their products or store with our bespoke warehousing options – all in a stunning, collaborative and inspirational campus environment. Thanks to Enterprise Zone status, businesses can also access a range of benefits – from free Wi-fi and funding advice to streamlined planning.

Whether you’re looking for start-up space to launch your business venture or a global headquarters for your company, we have all you need at Discovery Park to take your business to the next level.

Strategic Expertise, Operational Excellence.. . A forward thinking regulatory affairs consultancy with more than 250 cumulative years regulatory experience spanning many therapeutic specialities. We offer the full range of regulatory affairs services from strategic advice in early drug development, to compilation and management of regulatory submissions, and for over 10 years we have helped companies of all sizes and backgrounds maximise the commercial value of their product. We also understand the importance of a clear regulatory strategy and pathway to market which can maximise the value of an asset when negotiating out-licensing agreements, and our proactive collaborative interactions with Regulatory Authorities can improve chances of approval of a product in the optimal time.

Pages